1. Home
  2. DAKT vs PCRX Comparison

DAKT vs PCRX Comparison

Compare DAKT & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Daktronics Inc.

DAKT

Daktronics Inc.

HOLD

Current Price

$20.12

Market Cap

944.7M

Sector

Industrials

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$23.50

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAKT
PCRX
Founded
1968
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
944.7M
1.0B
IPO Year
1996
2010

Fundamental Metrics

Financial Performance
Metric
DAKT
PCRX
Price
$20.12
$23.50
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$30.25
AVG Volume (30 Days)
240.2K
527.9K
Earning Date
03-04-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
107.44
EPS
0.75
0.07
Revenue
$608,932,000.00
$541,533,000.00
Revenue This Year
$12.06
$6.78
Revenue Next Year
$9.16
$8.54
P/E Ratio
$26.87
$332.14
Revenue Growth
6.89
26.04
52 Week Low
$13.05
$18.80
52 Week High
$28.27
$27.64

Technical Indicators

Market Signals
Indicator
DAKT
PCRX
Relative Strength Index (RSI) 54.01 49.85
Support Level $18.99 $22.13
Resistance Level $20.55 $24.20
Average True Range (ATR) 0.56 1.02
MACD 0.04 -0.06
Stochastic Oscillator 64.53 42.93

Price Performance

Historical Comparison
DAKT
PCRX

About DAKT Daktronics Inc.

Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: